Added to YB: 2022-08-02
Pitch date: 2022-08-02
ANEB [bullish]
Anebulo Pharmaceuticals, Inc.
-23.92%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing treatments for unintentional cannabis poisoning, acute cannabinoid intoxication, and acute cannabis-induced conditions in the United States.
Market Cap
$93.7M
Pitch Price
$3.01
Price Target
N/A
Dividend
N/A
EV/EBITDA
N/A
P/E
-10.13
EV/Sales
N/A
Sector
Pharmaceuticals
Category
N/A
Show full summary:
Anebulo Pharmaceuticals ANEB
A summary for this pitch has not been created yet.
Read full article (0 min)